The authorization, issued jointly by the Food Standards Agency (FSA) and Food Standards Scotland (FSS), permits Curcumin C3 Reduct for use in food supplements at a maximum daily dose of 140 mg for adults aged 18 and older.<\/p>\n
\u201cReceiving novel food authorization in Great Britain is a significant achievement for our European operations and reflects the strength of the scientific dossier our team assembled in support of this application,\u201d said Dr. Umar Jan, president of European operations at Sabinsa.<\/p>\n
C3 Reduct\u2019s global regulatory status<\/p>\n
The authorization follows Sabinsa Europe GmbH\u2019s submission of a comprehensive safety dossier in 2023, including toxicology, genotoxicity, compositional and human studies. After reviewing the data, the FSA and FSS found no safety, allergenicity or stability concerns and concluded that the ingredient is safe for use at the proposed intake levels.<\/p>\n
\u201cThis authorization represents an important milestone for Curcumin C3 Reduct and underscores Sabinsa\u2019s commitment to rigorous science and regulatory transparency,\u201d said Dr. Shaheen Majeed, global CEO and managing director of Sabinsa.<\/p>\n
\u201cWe are pleased that both the FSA and FSS have concluded that our tetrahydrocurcuminoids ingredient is safe under the proposed conditions of use, and we look forward to supporting supplement brands in Great Britain with a fully authorized, well-characterized curcuminoid ingredient.\u201d<\/p>\n
The decision builds on a positive assessment from the European Food Safety Authority (EFSA) in 2021<\/a>, which established a safe intake level of 140 mg per day.<\/p>\n In the United States, Curcumin C3 Reduct holds self-affirmed Generally Recognized as Safe (GRAS) status, in Brazil, it became the first and only THC ingredient authorized by the National Health Surveillance Agency (ANVISA)<\/a> in early 2024, with approval for use at a daily dose of 120 mg. The ingredient has also gained regulatory acceptance in Canada, where authorities approved it as a Natural Health Product and recognized its antioxidant claim at a recommended dosage of 100 mg twice daily. <\/p>\n Sabinsa\u2019s curcumin C3 Reduct ingredient<\/p>\n Curcumin C3 Reduct is a purified ingredient derived from turmeric through catalytic hydrogenation of curcuminoids, a process that produces a powder that is 95% THCs. In the body, curcuminoids are normally converted into THCs through the action of gut bacteria and liver processes, but C3 Reduct is designed to bypass that conversion step by supplying THCs directly.<\/p>\n